Spyre Therapeutics, Inc. — SlamSEC

Spyre Therapeutics, Inc.

Nasdaq:SYRE

Pharmaceutical Preparations·WALTHAM, MA

Governanceproxy statements · beneficial ownership

Proxy Statements

17 shown

Filed	Form	Description
4/14/25	DEFA14A	DEFA14A	→
4/14/25	DEF 14A	DEF 14A	→
4/1/24	DEF 14A	DEF 14A	→
3/20/24	PRE 14A	PRE 14A	→
10/27/23	DEF 14A	DEF 14A	→
8/8/23	PRE 14A	PRE 14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
3/3/26	4	4	→
3/3/26	4	4	→
2/4/26	4	4	→
1/23/26	4	4	→
1/13/26	4	4	→
1/13/26	4	4	→
↓